256940 — Keeps BioPharma Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩202bn
- KR₩228bn
- KR₩128bn
- 16
- 28
- 52
- 18
Annual cashflow statement for Keeps BioPharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2,547 | -16,231 | -12,040 | 3,463 | 1,612 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2,716 | 8,605 | 6,034 | 698 | 5,129 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,510 | -1,567 | 4,147 | -5,660 | -4,514 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,737 | -8,380 | -866 | -57.1 | 4,808 |
| Capital Expenditures | -1,692 | -123 | -130 | -1,071 | -6,700 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -7,839 | -14,154 | -9,297 | -26,520 | -15,575 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -9,531 | -14,276 | -9,427 | -27,591 | -22,275 |
| Financing Cash Flow Items | -42.4 | -35.7 | -298 | -600 | 31,649 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 38,690 | 28,032 | -3,272 | 8,151 | 31,927 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 26,744 | 6,049 | -13,572 | -19,519 | 14,671 |